Skip to main content

SOPHiA GENETICS SA insider trading

SOPHNASDAQ
$8.20+0.13 (+1.61% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (+102.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

    AI Activity Analysis

    Premium
    Coming soonAI reads of insider activity will appear here for Premium accounts.

    Insider activity

    Fromto
    CompanyInsider / roleActionΔOwnAvg priceAmount
    SOPHGeorge CardozaChief Financial OfficerOpen market sell$6.45K-0.3%$8.33$6.45KSep 21, 2026Sep 22, 2026
    SOPHRoss MukenChief Executive OfficerOpen market sell$3.52K-0.1%$8.33$3.52KSep 21, 2026Sep 22, 2026
    SOPHPhilippe MenuChief Medical OfficerOpen market sell$39.4K-2.3%$7.88$39.4KSep 14, 2026Sep 16, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$31.5K-0.7%$7.88$31.5KSep 14, 2026Sep 16, 2026
    SOPHDaan van WellChief Legal OfficerOpen market sell$47.1K-1.8%$7.63$47.1KSep 11, 2026Sep 14, 2026
    SOPHJurgi CamblongExecutive ChairmanOpen market sell$65.1K-0.3%$7.66$65.1KSep 10, 2026Sep 14, 2026
    SOPHKathy L. HibbsDirectorOpen market sell$50.8K-6.1%$8.13$50.8KSep 8, 2026Sep 10, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$89.1K-1.8%$8.91$89.1KAug 27, 2026Aug 31, 2026
    SOPHPhilippe MenuChief Medical OfficerOpen market sell$43.4K-2.3%$8.68$43.4KAug 25, 2026Aug 26, 2026
    SOPHKathy L. HibbsDirectorOpen market sell$54.2K-5.7%$8.68$54.2KAug 25, 2026Aug 26, 2026
    SOPHAbhimanyu VermaChief Technology OfficerOpen market sell$44K-2.8%$8.80$44KAug 24, 2026Aug 26, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$45.4K-0.9%$8.40$45.4KAug 21, 2026Aug 21, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$38.6K-0.8%$8.41$38.6KAug 20, 2026Aug 21, 2026
    SOPHAbhimanyu VermaChief Technology OfficerOpen market sell$41K-2.7%$8.20$41KAug 19, 2026Aug 26, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$79.4K-1.7%$7.94$79.4KAug 19, 2026Aug 21, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$30.1K-0.7%$7.52$30.1KAug 13, 2026Aug 14, 2026
    SOPHPhilippe MenuChief Medical OfficerOpen market sell$37.6K-2.2%$7.52$37.6KAug 12, 2026Aug 14, 2026
    SOPHJurgi CamblongExecutive ChairmanOpen market sell$64.7K-0.3%$7.61$64.7KAug 10, 2026Aug 10, 2026
    SOPHAbhimanyu VermaChief Technology OfficerOpen market sell$38K-2.7%$7.60$38KAug 7, 2026Aug 10, 2026
    SOPHJurgi CamblongExecutive ChairmanOpen market sell$145K-0.6%$7.23$145KAug 7, 2026Aug 10, 2026
    SOPHAbhimanyu VermaChief Technology OfficerOpen market sell$34.8K-2.6%$6.95$34.8KAug 4, 2026Aug 5, 2026
    SOPHJurgi CamblongExecutive ChairmanOpen market sell$138K-0.6%$6.92$138KAug 4, 2026Aug 5, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$69.2K-1.6%$6.92$69.2KAug 4, 2026Aug 5, 2026
    SOPHPhilippe MenuChief Medical OfficerOpen market sell$28.3K-2.2%$5.66$28.3KJul 27, 2026Jul 28, 2026
    SOPHJurgi CamblongExecutive ChairmanOpen market sell$133K-0.6%$6.63$133KJul 21, 2026Jul 22, 2026
    SOPHPhilippe MenuChief Medical OfficerOpen market sell$28.5K-2.1%$5.70$28.5KJul 13, 2026Jul 14, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$22.8K-0.7%$5.70$22.8KJul 13, 2026Jul 14, 2026
    SOPHJurgi CamblongExecutive ChairmanOpen market sell$47.8K-0.2%$5.62$47.8KJul 10, 2026Jul 14, 2026
    SOPHJurgi CamblongExecutive ChairmanOpen market sell$93.3K-0.5%$5.28$93.3KJul 7, 2026Jul 8, 2026
    SOPHGeorge CardozaChief Financial OfficerOpen market sell$8.42K-0.5%$5.29$8.42KJul 6, 2026Jul 7, 2026
    SOPHManuela ValenteChief People OfficerOpen market sell$21.4K-2.0%$5.05$21.4KJul 6, 2026Jul 7, 2026
    SOPHAbhimanyu VermaChief Technology OfficerOpen market sell$27K-2.7%$5.10$27KJul 6, 2026Jul 7, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$38.2K-1.2%$5.17$38.2KJul 6, 2026Jul 7, 2026
    SOPHRoss MukenChief Executive OfficerOpen market sell$51.4K-1.5%$5.22$51.4KJul 6, 2026Jul 7, 2026
    SOPHKevin PuylaertChief Sales OfficerOpen market sell$1580.0%$5.09$158Jul 6, 2026Jul 7, 2026
    SOPHKevin PuylaertChief Sales OfficerOpen market sell$2360.0%$5.03$236Jul 6, 2026Jul 7, 2026
    SOPHKevin PuylaertChief Sales OfficerOpen market sell$693-0.1%$5.03$693Jul 6, 2026Jul 7, 2026
    SOPHPhilippe MenuChief Medical OfficerOpen market sell$38.2K-3.1%$5.16$38.2KJul 6, 2026Jul 7, 2026
    SOPHJurgi CamblongExecutive ChairmanOpen market sell$118K-0.6%$5.26$118KJul 6, 2026Jul 7, 2026
    SOPHJurgi CamblongChief Executive OfficerOpen market sell$7.83K0.0%$5.70$7.83KJun 25, 2026Jun 29, 2026
    SOPHAbhimanyu VermaChief Technology OfficerOpen market sell$38.3K-3.4%$5.51$38.3KJun 25, 2026Jun 26, 2026
    SOPHPhilippe MenuChief Medical OfficerOpen market sell$27.5K-2.0%$5.50$27.5KJun 25, 2026Jun 26, 2026
    SOPHGeorge CardozaChief Financial OfficerOpen market sell$4.16K-0.3%$5.38$4.16KJun 22, 2026Jun 23, 2026
    SOPHRoss MukenPresidentOpen market sell$2.27K-0.1%$5.38$2.27KJun 22, 2026Jun 23, 2026
    SOPHZhenyu XuChief Scientific OfficerOpen market sell$20K-0.6%$5.01$20KJun 15, 2026Jun 17, 2026
    SOPHPhilippe MenuChief Medical OfficerOpen market sell$24.8K-2.0%$4.95$24.8KJun 12, 2026Jun 15, 2026
    SOPHJurgi CamblongChief Executive OfficerOpen market sell$44.5K-0.2%$5.24$44.5KJun 10, 2026Jun 11, 2026
    SOPHGeorge CardozaChief Financial OfficerOpen market purchase$99K+6.9%$4.95$99KJun 5, 2026Jun 5, 2026
    SOPHPhilippe MenuChief Medical OfficerOpen market sell$24.8K-2.0%$4.95$24.8KMay 26, 2026Jun 1, 2026
    SOPHRoss MukenPresidentOpen market sell$3.5K-0.1%$4.60$3.5KMay 19, 2026May 20, 2026
    50 of 125 transactions

    Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.